Diabetes 51:1356-1361, 2002
© 2002 by the American Diabetes Association, Inc.
Leptin Accelerates Autoimmune Diabetes in Female NOD Mice
Giuseppe Matarese1,
Veronica Sanna2,
Robert I. Lechler3,
Nora Sarvetnick4,
Silvia Fontana2,
Serafino Zappacosta1, and
Antonio La Cava4
1 Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli "Federico II," Napoli, Italy
2 Centro di Endocrinologia e Oncologia Sperimentale del CNR, Napoli, Italy
3 Department of Immunology, Imperial College School of Medicine, Hammersmith Hospital, London, U.K.
4 Department of Immunology, the Scripps Research Institute, La Jolla, California
We have recently shown that leptin, the product of the obese gene, can directly influence T-cell function. In the work presented here, we explored the role of leptin in the development of spontaneous autoimmunity in the nonobese diabetic (NOD) mouse, an animal model for the study of human insulin-dependent diabetes mellitus (type 1 diabetes). We found that expression of serum leptin increased soon before the onset of hyperglycemia and diabetes in susceptible females. A pathogenetic role of leptin was assessed by administering recombinant leptin to young female and male NOD mice. Intraperitoneal injections of leptin accelerated autoimmune destruction of insulin-producing ß-cells and significantly increased interferon- production in peripheral T-cells. These findings indicate that leptin can favor proinflammatory cell responses and directly influence development of autoimmune disease mediated by Th1 responses.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Q. L. K. Lam, B.-J. Zheng, D.-Y. Jin, X. Cao, and L. Lu
Leptin Induces CD40 Expression through the Activation of Akt in Murine Dendritic Cells
J. Biol. Chem.,
September 21, 2007;
282(38):
27587 - 27597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. ALEXANDRAKI, C. PIPERI, C. KALOFOUTIS, J. SINGH, A. ALAVERAS, and A. KALOFOUTIS
Inflammatory Process in Type 2 Diabetes: The Role of Cytokines
Ann. N.Y. Acad. Sci.,
November 1, 2006;
1084(1):
89 - 117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Mansour, F. G. Pereira, E. P. Araujo, M. E. C. Amaral, J. Morari, N. R. Ferraroni, D. S. Ferreira, I. Lorand-Metze, and L. A. Velloso
Leptin Inhibits Apoptosis in Thymus through a Janus Kinase-2-Independent, Insulin Receptor Substrate-1/Phosphatidylinositol-3 Kinase-Dependent Pathway
Endocrinology,
November 1, 2006;
147(11):
5470 - 5479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Perone, S. Bertera, Z. S. Tawadrous, W. J. Shufesky, J. D. Piganelli, L. G. Baum, M. Trucco, and A. E. Morelli
Dendritic Cells Expressing Transgenic Galectin-1 Delay Onset of Autoimmune Diabetes in Mice
J. Immunol.,
October 15, 2006;
177(8):
5278 - 5289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Otero, R. Lago, R. Gomez, C. Dieguez, F. Lago, J. Gomez-Reino, and O. Gualillo
Towards a pro-inflammatory and immunomodulatory emerging role of leptin
Rheumatology,
August 1, 2006;
45(8):
944 - 950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. HARLE and R. H. STRAUB
Leptin Is a Link between Adipose Tissue and Inflammation
Ann. N.Y. Acad. Sci.,
June 1, 2006;
1069(1):
454 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Oral, E. D. Javor, L. Ding, G. Uzel, E. K. Cochran, J. R. Young, A. M. DePaoli, S. M. Holland, and P. Gorden
Leptin Replacement Therapy Modulates Circulating Lymphocyte Subsets and Cytokine Responsiveness in Severe Lipodystrophy
J. Clin. Endocrinol. Metab.,
February 1, 2006;
91(2):
621 - 628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Lee, Y.-G. Chen, J. Chen, P. C. Reifsnyder, D. V. Serreze, M. Clare-Salzler, M. Rodriguez, C. Wasserfall, M. A. Atkinson, and E. H. Leiter
Novel Leptin Receptor Mutation in NOD/LtJ Mice Suppresses Type 1 Diabetes Progression: II. Immunologic Analysis
Diabetes,
January 1, 2006;
55(1):
171 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Donath, J. A. Ehses, K. Maedler, D. M. Schumann, H. Ellingsgaard, E. Eppler, and M. Reinecke
Mechanisms of {beta}-Cell Death in Type 2 Diabetes
Diabetes,
December 1, 2005;
54(suppl_2):
S108 - S113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Leiter and C.-H. Lee
Mouse Models and the Genetics of Diabetes: Is There Evidence for Genetic Overlap Between Type 1 and Type 2 Diabetes?
Diabetes,
December 1, 2005;
54(suppl_2):
S151 - S158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Lee, P. C. Reifsnyder, J. K. Naggert, C. Wasserfall, M. A. Atkinson, J. Chen, and E. H. Leiter
Novel Leptin Receptor Mutation in NOD/LtJ Mice Suppresses Type 1 Diabetes Progression: I. Pathophysiological Analysis
Diabetes,
September 1, 2005;
54(9):
2525 - 2532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kagohashi, J. Udagawa, N. Abiru, M. Kobayashi, K. Moriyama, and H. Otani
Maternal Factors in a Model of Type 1 Diabetes Differentially Affect the Development of Insulitis and Overt Diabetes in Offspring
Diabetes,
July 1, 2005;
54(7):
2026 - 2031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Matarese, P. B. Carrieri, A. La Cava, F. Perna, V. Sanna, V. De Rosa, D. Aufiero, S. Fontana, and S. Zappacosta
Leptin increase in multiple sclerosis associates with reduced number of CD4+CD25+ regulatory T cells
PNAS,
April 5, 2005;
102(14):
5150 - 5155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Matarese, S. Moschos, and C. S. Mantzoros
Leptin in Immunology
J. Immunol.,
March 15, 2005;
174(6):
3137 - 3142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Chan, S. J. Moschos, J. Bullen, K. Heist, X. Li, Y.-B. Kim, B. B. Kahn, and C. S. Mantzoros
Recombinant Methionyl Human Leptin Administration Activates Signal Transducer and Activator of Transcription 3 Signaling in Peripheral Blood Mononuclear Cells in Vivo and Regulates Soluble Tumor Necrosis Factor-{alpha} Receptor Levels in Humans with Relative Leptin Deficiency
J. Clin. Endocrinol. Metab.,
March 1, 2005;
90(3):
1625 - 1631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Siegmund, J. A. Sennello, H. A. Lehr, A. Batra, I. Fedke, M. Zeitz, and G. Fantuzzi
Development of intestinal inflammation in double IL-10- and leptin-deficient mice
J. Leukoc. Biol.,
October 1, 2004;
76(4):
782 - 786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Peelman, K. Van Beneden, L. Zabeau, H. Iserentant, P. Ulrichts, D. Defeau, A. Verhee, D. Catteeuw, D. Elewaut, and J. Tavernier
Mapping of the Leptin Binding Sites and Design of a Leptin Antagonist
J. Biol. Chem.,
September 24, 2004;
279(39):
41038 - 41046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Palmer and C Gabay
A role for leptin in rheumatic diseases?
Ann Rheum Dis,
October 1, 2003;
62(10):
913 - 915.
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Imagawa, T. Funahashi, T. Nakamura, M. Moriwaki, S. Tanaka, H. Nishizawa, K. Sayama, S. Uno, H. Iwahashi, K. Yamagata, et al.
Elevated Serum Concentration of Adipose-Derived Factor, Adiponectin, in Patients With Type 1 Diabetes
Diabetes Care,
September 1, 2002;
25(9):
1665 - 1666.
[Full Text]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|